Citation: | JIANG Su-rong, CAO Ya-ru, WANG Ying-ying, WANG Xiao-yan, HONG Jian, GUO Yan. Correlation between 25-hydroxyvitamin D deficiency and heart failure with preserved ejection fraction in the elderly[J]. Chinese Journal of General Practice, 2021, 19(11): 1815-1818, 1835. doi: 10.16766/j.cnki.issn.1674-4152.002174 |
[1] |
BORLAUG B A. Evaluation and management of heart failure with preserved ejection fraction[J]. Nat Rev Cardiol, 2020, 17(9): 559-573. doi: 10.1038/s41569-020-0363-2
|
[2] |
黄鑫, 孔红娇, 朱明娜, 等. 老年射血分数保留型心力衰竭患者不同性别相关因素分析及增强型体外反搏安全性观察[J]. 中华全科医学, 2021, 19(4): 564-567. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202104011.htm
|
[3] |
NOWAK J, HUDZIK B, JAGIELSKI P, et al. Lack of seasonal variations in vitamin D concentrations among hospitalized elderly patients[J]. Int J Environ Res Public Health, 2021, 18(4): 1676. doi: 10.3390/ijerph18041676
|
[4] |
UMAR M, SASTRY K S, CHOUCHANE A I. Role of vitamin D beyond the skeletal function: A review of the molecular and clinical studies[J]. Int J Mol Sci, 2018, 19(6): 1618. doi: 10.3390/ijms19061618
|
[5] |
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789. doi: 10.3760/cma.j.issn.0253-3758.2018.10.004
|
[6] |
ALQUAIZ A M, ALRASHEED A A, KAZI A, et al. Is 25-hydroxyvitamin D associated with glycosylated hemoglobin in patients with type 2 diabetes mellitus in Saudi Arabia?A population based study[J]. Int J Environ Res Public Health, 2021, 18(6): 2805. doi: 10.3390/ijerph18062805
|
[7] |
LATIC N, ERBEN R G. Vitamin D and cardiovascular disease, with emphasis on hypertension, atherosclerosis and heart failure[J]. Int J Mol Sci, 2020, 21(18): 6483. doi: 10.3390/ijms21186483
|
[8] |
ROFFE-VAZQUEZ D N, HUERTA-DELGADO A S, CASTILLO E C, et al. Correlation of vitamin D with inflammatory cytokines, atherosclerotic parameters, and lifestyle factors in the setting of heart failure: A 12-month follow-up study[J]. Int J Mol Sci, 2019, 20(22): 5811. doi: 10.3390/ijms20225811
|
[9] |
UPADHYA B, KITZMAN D W. Heart failure with preserved ejection fraction: New approaches to diagnosis and management[J]. Clin Cardiol, 2020, 43(2): 145-155. doi: 10.1002/clc.23321
|
[10] |
曹雅雯, 毕颖斐, 王贤良, 等. 芪苈强心胶囊对射血分数保留心力衰竭患者心功能影响的系统评价[J]. 中国循证医学杂志, 2020, 20(12): 1427-1433. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXZ202012011.htm
|
[11] |
TEMMA T, NAGAI T, WATANABE M, et al. Differential prognostic impact of atrial fibrillation in hospitalized heart failure patients with preserved ejection fraction according to coronary artery disease Status-report from the Japanese nationwide multicenter registry[J]. Circ J, 2020, 84(3): 397-403. doi: 10.1253/circj.CJ-19-0963
|
[12] |
GUPTA K, KALRA R, RAJAPREYAR I, et al. Anemia, mortality, and hospitalizations in heart failure with a preserved ejection fraction(from the TOPCAT Trial)[J]. Am J Cardiol, 2020, 125(9): 1347-1354. doi: 10.1016/j.amjcard.2020.01.046
|
[13] |
SAVARESE G, ORSINI N, HAGE C, et al. Utilizing NT-proBNP for eligibility and enrichment in trials in HFpEF, HFmrEF, and HFrEF[J]. JACC Heart Fail, 2018, 6(3): 246-256. doi: 10.1016/j.jchf.2017.12.014
|
[14] |
NOLTE K, HERRMANN-LINGEN C, PLATSCHEK L, et al. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction[J]. ESC Heart Fail, 2019, 6(2): 262-270. doi: 10.1002/ehf2.12413
|
[15] |
WANG T, LIU Z, FU J, et al. Meta-analysis of vitamin D supplementation in the treatment of chronic heart failure[J]. Scand Cardiovasc J, 2019, 53(3): 110-116. doi: 10.1080/14017431.2019.1612084
|